The aim of the present study was to assess the development of microangiopathy in patients with fulminant type 1 diabetes, a novel subtype of type 1B diabetes.
First Department of Internal Medicine, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, and Department of Metabolism/Diabetes and Clinical Nutrition, Nagasaki University Hospital of Medicine and Dentistry, Japan.